Radiopharm Theranostics Limited American Depositary Shares (RADX) — Strategic Asset Allocation Index
Radiopharm Theranostics Limited American Depositary Shares (RADX) has a Strategic Asset Allocation Index of 0.1% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $40.00K) total $40.00K, measured against net assets of $52.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Radiopharm Theranostics Limited American leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
SAAI
Strategic Assets
PP&E
Net Assets
Radiopharm Theranostics Limited American Depositary Shares Strategic Asset Allocation Index (2024–2025)
This chart shows how Radiopharm Theranostics Limited American Depositary Shares's Strategic Asset Allocation Index has evolved across 2 annual periods from 2024 to 2025. As of December 2024, the index stands at 0.1%, representing strategic assets of $40.00K against net assets of $52.00 Million USD. See RADX net asset quality score to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Radiopharm Theranostics Limited American Depositary Shares (2024–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Radiopharm Theranostics Limited American Depositary Shares from 2024 to 2025, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see RADX stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.0% | $0.00 | $- | $0.00 | $42.87 Million | ▼ -0.1 pp |
| 2024 | 0.1% | $40.00K | $- | $40.00K | $27.35 Million | — |